Bromocriptine Capsules and Reteplase, recombinant Intravenous
Determining the interaction of Bromocriptine Capsules and Reteplase, recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bromocriptine
Brand name: Parlodel, Cycloset
Synonyms: Bromocriptine
Generic Name: reteplase
Brand name: Retavase, Retavase Half-Kit
Synonyms: Reteplase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bromocriptine Capsules-Retin A
- Bromocriptine Capsules-Retin-A (Tretinoin Cream)
- Bromocriptine Capsules-Retin-A (Tretinoin Gel)
- Bromocriptine Capsules-Retin-A Cream, Gel, Liquid
- Bromocriptine Capsules-Retin-A Micro
- Bromocriptine Capsules-Retin-A Micro Topical
- Reteplase, recombinant Intravenous-Bromocriptine Mesylate
- Reteplase, recombinant Intravenous-Brompheniramine
- Reteplase, recombinant Intravenous-Brompheniramine and codeine
- Reteplase, recombinant Intravenous-Brompheniramine and phenylephrine
- Reteplase, recombinant Intravenous-Brompheniramine and Phenylephrine Chewable Tablets
- Reteplase, recombinant Intravenous-Brompheniramine and Phenylephrine Liquid